Drug Trial Radar · NCT05987241
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
992
Planned (sponsor's estimate)
Start
Feb 2, 2024
Primary completion
Sep 2, 2030
Study completion Sep 2, 2030
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Aug 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment called immunotherapy to help prevent their urinary tract (urothelial) cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or release different types of cellular products including their DNA which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes can be seen on scans. Health care providers can measure the level of ctDNA in blood or other bodily fluids to determine which patients are at higher risk for disease progression or relapse. In this study, a blood test is used to measure ctDNA and see if there is still cancer somewhere in the body after surgery and if giving a treatment will help eliminate the cancer. Immunotherapy with monoclonal antibodies, such as nivolumab and relatlimab, can help the body's immune system to attack the cancer, and can interfere with the ability of tumor cells to grow and spread. This trial may help doctors determine if ctDNA measurement in blood can better identify patients that need additional treatment, if treatment with nivolumab prolongs patients' life and whether the additional immunotherapy treatment with relatlimab extends time without disease progression or prolongs life of urothelial cancer patients who have undergone surgical removal of their bladder, kidney, ureter or urethra.
Conditions
- Muscle Invasive Bladder Urothelial Carcinoma
- Muscle Invasive Renal Pelvis Urothelial Carcinoma
- Muscle Invasive Ureter Urothelial Carcinoma
- Muscle Invasive Urethral Urothelial Carcinoma
- Stage II Bladder Urothelial Carcinoma AJCC v6 and v7
- Stage III Bladder Urothelial Carcinoma AJCC v6 and v7
- Stage IV Bladder Urothelial Carcinoma AJCC v7
Interventions
Biospecimen CollectionProcedure
Undergo collection of tissue and blood
cfDNA or ctDNA MeasurementOther
Undergo ctDNA surveillance
Computed TomographyProcedure
Undergo CT
CystoscopyProcedure
Undergo cystoscopy
Magnetic Resonance ImagingProcedure
Undergo MRI
NivolumabBiological
Given IV
Questionnaire AdministrationOther
Ancillary studies
RelatlimabBiological
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients who are circulating tumor DNA negative (ctDNA[-]) (Cohort A Phase II)Time frame: At week 12 from treatment start date
- Overall survival (OS) (Cohort A Phase III)Time frame: From randomization until death due to any cause, assessed up to 5 years after completion of study treatment
- Disease-Free Survival (DFS) (Cohort B)Time frame: From randomization until confirmed disease recurrence as assessed by the treating physician or death due to any cause, assessed up to 5 years after completion of study treatment
Locations
505 sites in 2 countries. Site status is shown where the registry gives one.
Cancer Center at Saint Joseph's
Phoenix, Arizona · Recruiting
Mayo Clinic Hospital in Arizona
Phoenix, Arizona · Recruiting
University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona · Suspended
Banner University Medical Center - Tucson
Tucson, Arizona · Recruiting
University of Arizona Cancer Center-North Campus
Tucson, Arizona · Recruiting
Highlands Oncology Group - Fayetteville
Fayetteville, Arkansas · Recruiting
Highlands Oncology Group - Rogers
Rogers, Arkansas · Recruiting
Highlands Oncology Group
Springdale, Arkansas · Recruiting
Kaiser Permanente-Anaheim
Anaheim, California · Recruiting
Kaiser Permanente-Baldwin Park
Baldwin Park, California · Recruiting
Kaiser Permanente-Bellflower
Bellflower, California · Recruiting
Kaiser Permanente Dublin
Dublin, California · Recruiting
Kaiser Permanente-Fontana
Fontana, California · Recruiting
Kaiser Permanente-Fremont
Fremont, California · Recruiting
Kaiser Permanente Fresno Orchard Plaza
Fresno, California · Recruiting
Kaiser Permanente-Fresno
Fresno, California · Recruiting
Kaiser Permanente South Bay
Harbor City, California · Recruiting
Kaiser Permanente-Irvine
Irvine, California · Recruiting
UC San Diego Moores Cancer Center
La Jolla, California · Recruiting
Keck Medicine of USC Koreatown
Los Angeles, California · Active not recruiting
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California · Recruiting
Los Angeles General Medical Center
Los Angeles, California · Active not recruiting
USC / Norris Comprehensive Cancer Center
Los Angeles, California · Active not recruiting
Kaiser Permanente West Los Angeles
Los Angeles, California · Recruiting
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California · Recruiting
Kaiser Permanente- Modesto MOB II
Modesto, California · Recruiting
Kaiser Permanente-Modesto
Modesto, California · Recruiting
USC Norris Oncology/Hematology-Newport Beach
Newport Beach, California · Active not recruiting
Kaiser Permanente-Oakland
Oakland, California · Recruiting
Kaiser Permanente-Ontario
Ontario, California · Recruiting
Stanford Cancer Institute Palo Alto
Palo Alto, California · Recruiting
Kaiser Permanente - Panorama City
Panorama City, California · Recruiting
Kaiser Permanente-Riverside
Riverside, California · Recruiting
Kaiser Permanente-Roseville
Roseville, California · Recruiting
Kaiser Permanente Downtown Commons
Sacramento, California · Recruiting
University of California Davis Comprehensive Cancer Center
Sacramento, California · Recruiting
Kaiser Permanente-South Sacramento
Sacramento, California · Recruiting
Kaiser Permanente-San Diego Zion
San Diego, California · Recruiting
Kaiser Permanente-San Francisco
San Francisco, California · Recruiting
Kaiser Permanente-Santa Teresa-San Jose
San Jose, California · Recruiting
Showing 40 of 505 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.